Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 5Completed 3Terminated 2Recruiting 2Unknown 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 6Urinary Bladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 4Glioblastoma 3Esophageal Squamous Cell Carcinoma 3Radiation Injuries 2Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lung Neoplasms 2Invasive Breast Cancer 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Brain Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Thyroid Neoplasms 1Stomach Neoplasms 1Stomach Diseases 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Respiratory Aspiration 1Prostate Adenocarcinoma 1Premenopausal Breast Cancer 1

Interventions

Gemcitabine 19pembrolizumab 17Cisplatin 17Nivolumab 15atezolizumab 12Magnetic Resonance Spectroscopy 10durvalumab 9Specimen Handling 9Cystectomy 9Carboplatin 7Ipilimumab 6Fluorouracil 6avelumab 5Surgical Procedures, Operative 5Mitomycin 5sacituzumab govitecan 4erdafitinib 4enfortumab vedotin 4Immunoglobulin G 4Disulfides 4Biopsy 4tremelimumab 3cabozantinib 3Transurethral Resection of Bladder 3Surveys and Questionnaires 3Radiation 3Platinum 3Paclitaxel 3Leucovorin 3Docetaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Urinary Bladder Neoplasms × Surgical Procedures, Operative × Clear all
NCT06305767 2026-01-13

INTerpath-005

Merck Sharp & Dohme LLC

Phase 1/2 Active not recruiting
230 enrolled
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Active not recruiting
20 enrolled 11 charts
Genitourinary

Urinary Bladder Neoplasms

NCT03924856 2025-08-28

KEYNOTE-866

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
907 enrolled
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03924895 2025-08-28

KEYNOTE-905

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
595 enrolled 1 FDA
Genitourinary

Urinary Bladder Neoplasms

NCT00938145 2025-04-11

3 Tesla MRI in Patients With Bladder Cancer

University of Cincinnati

Phase NA Active not recruiting
98 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡